Uncategorized Archives - Page 87 of 249

MondayJan 11, 2021 12:04 pm

CannAssist International Corp.’s (CNSC) Proprietary Technology Offers Superior Absorption, Efficacy

Imperial College of London review suggests that cannabis-based medicinal products offer significant relief from intractable epilepsy CNSC produces proprietary CBD products under the Xceptol brand that are created with branded Technology CiBiDinol that increases absorbability, bioavailability, shelf life Third-party Xceptol testing shows 300% increased gut absorption, 400% increased skin penetration when compared to mainstream CBD oil products Researchers from the Imperial College of London recently conducted a review that examined the impact of cannabis-based medicinal products containing cannabidiol (“CBD”) on the frequency of epileptic seizures and determined that they offer patients significant relief from intractable epilepsy (https://cnw.fm/XL0hJ). As scientific evidence supporting…

ThursdayJan 07, 2021 1:10 pm

CannAssist International Corp. (CNSC) Flagship Brand Approved, Included by Powerful Online Platform

Acceptance of Xceptol products on RangeMe website new revenue source, increasing SKUs and access to retailers RangeMe enables retail buyers to discover innovative, emerging products; empowers suppliers to manage, grow their brands CannAssist developed Xceptol brand to offer effective health and wellness solutions without side effects CannAssist International (OTCQB: CNSC) has announced that its flagship brand — Xceptol — has been approved and included by the distribution website RangeMe (https://www.cnw.fm/vRWf4). Xceptol's inclusion on the website means increasing SKUs, access to more than 10,000 retailers, and a significant new revenue source for CNSC. "This is exciting news for us on many fronts,"…

WednesdayJan 06, 2021 2:03 pm

Pure Extracts Technologies (CSE: PULL) Draws Out Expansion Plans in Anticipation of Regulatory Changes Within Mushroom Sector

Pure Extracts Technologies Corp. has announced plans to expand, build fourth unit in dedicated towards research, development of psilocybin Announcement on its expansion plans come shortly after the Company revealed it plans to apply to Health Canada for a Dealer’s License Award of Dealer’s License would allow Pure Extracts to cultivate, harvest and procure controlled substances and carry out research into psychedelic compounds such as psilocybin and psilocin – paving way towards future commercialization of its product The Dealer’s License application has taken on increased relevance following Health Canada’s decision to revise existing regulations to permit certain authorized uses of…

WednesdayJan 06, 2021 12:58 pm

CannAssist International Corp.’s (CNSC) Proprietary CiBiDinol Technology Promises to Outperform Conventional CBD Oil for Superior Pain-Relief

Market for CBD-based pain relief products is growing rapidly, projected to reach $20 billion by 2024 CNSC is a biotech company that produces fast-acting CBD products under the Xceptol brand Xceptol products are formulated with exclusive technology that increases absorbability, bioavailability, shelf life Third-party testing on Xceptol suggests 400% increase in skin penetration, 300% increase in gut absorption when compared to regular oil-based CBD CannAssist International (OTCQB: CNSC), owner of Xceptor Labs, is a biotechnological pharmaceutical and wellness company marketing the Xceptol consumer brand - a line of cannabidiol (“CBD”) products that promises increased absorption, bioavailability and longer shelf life.…

TuesdayDec 29, 2020 12:41 pm

Gage Cannabis Co. Announces $20 Million Investment from JW Asset Management as Reg A Offering Closes the General Public Access

Gage Cannabis secures minimum $20 million investment from JWAM to expand cultivation and retail footprint, pursue accretive acquisitions, and solidify position as leading operator in the state of Michigan JW Asset Management is widely recognized as one of the premier investors in the cannabis sector In just over a year, Gage operations have grown to five provisioning centers, three cultivation facilities, and one processing facility As general public access for its Regulation A, Tier 2, equity financing closed, Gage Cannabis Co. announced that it has secured a minimum $20 million investment from JW Asset Management LLC (“JWAM”) as part of…

WednesdayDec 23, 2020 1:35 pm

Green Hygienics Holdings Inc. (GRYN) Is ‘One to Watch’

Green Hygienics owns the largest single USDA Certified Organic hemp farm in North America, with 824 acres of USDA Certified Organic outdoor cultivation potential and a further 400,000 square feet of greenhouse space. Green Hygienics is a real estate-backed investment with a valuation on the current farm property of $23 million The company has strong revenue growth potential by virtue of its acreage and ability to deliver products year-around through its indoor cultivation space (the average hemp farm in North America is approximately 15 acres). This, coupled with the direction the company is going with its own processing, directly addresses…

WednesdayDec 23, 2020 12:57 pm

Pure Extracts Technologies (CSE: PULL) Signs LOI with PURICA(TM) to Further Research into Mushrooms Wellness Products

Pure Extracts Technologies revealed it had recently retained global consultancy to advise on application for Dealer’s License under Health Canada If granted, license would allow Company to cultivate, conduct research into, commercialize controlled substances Pure Extracts also announced it recently signed LOI to further cooperation with PURICA(TM)( in field of full-spectrum mushroom-derived wellness products and co-develop CBD, mushroom product combinations Partnership would ideally situate Company to benefit from growing consumer interest within functional mushroom - CBD oil wellness product segments Pure Extracts Technologies (CSE: PULL) (XFRA: A2QJAJ), a plant-based extraction company, recently revealed that it had begun the process towards…

MondayDec 21, 2020 1:20 pm

CannAssist International Corp. (CNSC) Engages Communications Industry Leader IBN to Share Story, Reach Millions

CNSC partners with InvestorBrandNetwork to maximize communication, refine messaging and outreach. CannAssist focused on marketing Xceptol consumer brand, which provides products featuring proprietary CiBiDinol technology. IBN brings 15-plus years of experience assisting more than 500 client partners improve communications within investment community. Recognizing the critical nature of communications to the success of a business, CannAssist International (OTCQB: CNSC) has selected to partner with InvestorBrandNetwork (“IBN”), a multifaceted financial news and publishing company for private and public entities (https://cnw.fm/s0eOs). CannAssist, a biotechnological pharmaceutical and wellness company, owns Xceptor Labs, an R&D and raw material manufacturer, which also has its own product line. “We are pleased…

MondayDec 21, 2020 11:05 am

Pure Extracts Technologies Corp. (CSE: PULL) Names Key Advisor; Targets Development of Mushroom Formulations

Pure Extracts is working with Dr. Alexander MacGregor on development of mushroom products, including some combined with CBD. MacGregor is widely renowned as pharmaceutical science inventor, expert in pharmaceutical technology and novel drug-delivery systems. Pure Extracts is focused on expansion of its cannabis extraction business model to include mushroom formulations. Pure Extracts Technologies (CSE: PULL) has established a key collaborative relationship with an expert in translating pharmaceutical knowledge into a sustainable business. The plant-based extraction company, which is focused on cannabis, hemp and the rapidly emerging functional mushroom sector, is working closely with Dr. Alexander MacGregor on developing quality cannabis…

ThursdayDec 17, 2020 1:53 pm

Pure Extract Technologies (CSE: PULL) Provides Update on Expansion into Functional Mushrooms Sector

Pure Extracts Technologies recently provided update into its expansion into functional mushrooms sector Functional mushrooms have enjoyed surge in popularity as of late, are increasingly being used in wide variety of healthcare, pharmaceutical products Functional mushrooms sector is expected to grow to annual market value of $34.4 billion by 2024 Pure Extracts plans to develop high bio-available products derived from functional mushrooms through use of its proprietary extraction processes Company also set to launch its own branded functional mushrooms-based products under ‘Pure Mushrooms’ brand from Q1 2021 onwards and has signed a LOI with the PURICA(TM) brand of mushroom wellness…

News and publishing service for cannabis related companies

Contact us: 512.354.7000

Category: Uncategorized